Stereotactic ablative radiotherapy in combination with nivolumab for early stage operable non-small cell lung cancer: A phase II study

被引：0

作者：

Schvartsman, G. ^{[1
]}

Amarato, Y. ^{[2
]}

dos Santos, G. Prado ^{[3
]}

Gomes, D. Bugano Diniz ^{[4
]}

Koch, L. D. O. ^{[4
]}

Bibas, B. ^{[5
]}

Gomes, O., Jr. ^{[5
]}

Campregher, P. Vidal ^{[6
]}

Severino, P. ^{[3
]}

Marti, L. Cavalheiro ^{[3
]}

Ribeiro, V. Paes ^{[7
]}

Leaden, L. ^{[3
]}

Chate, R. Caruso ^{[8
]}

de Campos, J. Ribas Milanez ^{[5
]}

Sousa, V. A. Ramos ^{[9
]}

Taranto, P. ^{[9
]}

Moura, F. S. ^{[10
]}

Terra, R. M. ^{[11
]}

Rezende, A. C. P. D. ^{[12
]}

Samano, M. Naoyuki ^{[5
]}

机构：

[1] Albert Einstein Israelite Hosp, Dept Med Oncol, Sao Paulo, Brazil

[2] Faculdade Israelita Ciencias, Saude Albert Einstein, Sao Paulo, Brazil

[3] Albert Einstein Israelite Hosp, Acad Res Org, Sao Paulo, Brazil

[4] Albert Einstein Israelite Hosp, Dept Med Oncol, Sao Paulo, Brazil

[5] Albert Einstein Israelite Hosp, Dept Thorac Surg, Sao Paulo, Brazil

[6] Hosp Israelita Albert Einstein Unidade Morumbi, Dept Med Genet, Sao Paulo, Brazil

[7] Albert Einstein Israelite Hosp, Dept Pathol, Sao Paulo, Brazil

[8] Albert Einstein Israelite Hosp, Dept Radiol, Sao Paulo, Brazil

[9] Hosp Israelita Albert Einstein Morumbi Pavilhao V, Dept Med Oncol, Sao Paulo, Brazil

[10] Hosp Israelita Albertstein Morumbi Pavilhao Vick, Dept Med Oncol, Sao Paulo, Brazil

[11] ICESP Inst Canc Estado Sao Paulo, Dept Thorac Surg, Sao Paulo, Brazil

[12] Hosp Israelita Albert Einstein, Radiat Oncol, Sao Paulo, Brazil

来源：

ANNALS OF ONCOLOGY | 2024年 / 35卷

关键词：

D O I：

10.1016/j.annonc.2024.08.1280

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1221P

引用

页码：S785 / S785

页数：1

共 50 条

[41] Nomogram Predicting Overall Survival Benefit of Stereotactic Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancer
Jacobs, Corbin D.
Mehta, Kurren
Gao, Junheng
Wang, Xiaofei
Salama, Joseph K.
Kelsey, Chris R.
Torok, Jordan A.
CLINICAL LUNG CANCER, 2022, 23 (02) : 177 - 184
[42] Audit of radiotherapy plan quality for stereotactic ablative radiotherapy (SABR) for stage 1 non-small cell lung cancer
Pascoe, A. C.
Foweraker, K.
Esler, C.
Morgan, S.
Wallace, A.
Launders, D.
Harron, E.
CLINICAL ONCOLOGY, 2016, 28 : S4 - S4
[43] Worldwide Utilization of Stereotactic Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancer: Are We All in Sync?
Alfaifi, S.
Louie, A. V.
Siva, S.
Guckenberger, M.
Videtic, G. M.
Higgins, K.
Alshafa, F.
AlGhamdi, H.
Gillespie, E. F.
Stephans, K. L.
Mula-Hussain, L.
Harrow, S.
Palma, D. A.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E1 - E2
[44] Stereotactic ablative radiotherapy in treatment of early-stage non-small cell lung cancer: Unsolved questions and frontiers ahead
Zhang, Jingze
Kong, Li
Jiao, Qinghua
Li, Minghuan
Yu, Jingming
CANCER LETTERS, 2017, 401 : 46 - 52
[45] Surgery versus stereotactic ablative radiotherapy (SABR) for early-stage non-small cell lung cancer: less is not more
White, Abby
Swanson, Scott J.
JOURNAL OF THORACIC DISEASE, 2016, 8 : S399 - S405
[46] The Role of Stereotactic Ablative Radiotherapy for Early-Stage and Oligometastatic Non-small Cell Lung Cancer: Evidence for Changing Paradigms
Dahele, Max
Senan, Suresh
CANCER RESEARCH AND TREATMENT, 2011, 43 (02): : 75 - 82
[47] SYSTEMATIC REVIEW OF ECONOMIC EVALUATIONS ON STEREOTACTIC ABLATIVE RADIOTHERAPY FOR THE TREATMENT OF EARLY-STAGE NON-SMALL CELL LUNG CANCER
Maia, De Albuquerque F.
Rozman, L.
Carvalho, De Andrade H.
De Soarez, P. C.
VALUE IN HEALTH, 2022, 25 (01) : S48 - S48
[48] Immune Activation in Early Stage Non-Small Cell Lung Cancer (NSCLC) following Stereotactic Ablative Radiotherapy (SABR) and Surgery
Aerts, Joachim G.
De Goeje, Pauline
Schram, Merel
Bezemer, Koen
Kaijen-Lambers, Margaretha
Hegmans, Joost
De langen, Joop
Maat, Alexander
Nuyttens, Joost
Hendriks, Rudi
Smit, Egbert
Senan, Suresh
JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S326 - S326
[49] Stereotactic ablative radiotherapy for early stage non-small cell lung cancer: A critical literature review of predictive factors of relapse
Loganadane, Gokoulakrichenane
Martinetti, Florent
Mercier, Olaf
Krhili, Samar
Riet, Francois-Georges
Mbagui, Rodrigue
To, Hanh
Le Pechoux, Cecile
Levy, Antonin
CANCER TREATMENT REVIEWS, 2016, 50 : 240 - 246
[50] STEREOTACTIC BODY ABLATIVE RADIOTHERAPY FOR STAGE I NON SMALL CELL LUNG CANCER
Beltramo, G.
Bergantin, A.
Martinotti, A.
Bonfanti, P.
Bianchi, L. C.
RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S570 - S571

← 1 2 3 4 5 →